- Published on: September 30, 2021
- 00:30
Moscow, Sep 30 (Prensa Latina) Veronika Skvortsova, director of the Federal Medical-Biological Agency (FMBA), said that Russia's new Covid-19 vaccine candidate has proven efficacy and safety in preclinical trials.